Elutia (ELUT) Return on Capital Employed Growth (1y) (2021 - 2026)
Elutia (ELUT) Return on Capital Employed Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.00 Bn | 175.71 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.69 Bn | 125.81 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 68.39 Bn | 66.93 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 47.97 Bn | 44.30 Bn | 1.29 Bn | -110.00 |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.00 Bn | 1.98 Bn | -3,185.00 |
| 7 | Dexcom | 28.21 Bn | 27.09 Bn | 750.30 Mn | 658.00 |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 125.00 |
| 10 | Elutia | 39.14 Mn | 10.65 Mn | 1.80 Mn | 362,531.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 362,531.00 |
| Dec 31, 2025 | 61,480.00 |
| Sep 30, 2025 | 93,505.00 |
| Jun 30, 2025 | -37,567.00 |
| Mar 31, 2025 | -139,590.00 |
| Dec 31, 2024 | -24,024.00 |
| Sep 30, 2024 | -27,116.00 |
| Jun 30, 2024 | 304,074.00 |
| Mar 31, 2024 | -215,906.00 |
| Dec 31, 2023 | -36,104.00 |
| Sep 30, 2023 | -17,201.00 |
| Jun 30, 2023 | -10,557.00 |
| Mar 31, 2023 | -7,774.00 |
| Dec 31, 2022 | -8,919.00 |
| Sep 30, 2022 | -14,434.00 |
| Jun 30, 2022 | -10,699.00 |
| Mar 31, 2022 | -4,620.00 |
| Dec 31, 2021 | -2,529.00 |